SökerData provides curated, unbiased health datasets sourced from diverse populations to train artificial intelligence models. The platform supports early drug discovery by visualizing data to highlight disease outcome biomarkers across various demographics. This service aids researchers in making informed decisions for clinical trial progression and biomarker identification.
Funding
$7.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Existing health datasets often lack representation from diverse populations, leading to biased biomarker visualization and unreliable clinical outcomes, particularly in early drug discovery and clinical trials. This absence of unbiased data from minority groups hinders the development of effective and equitable treatments.
Solution
SökerData provides curated health datasets that specifically represent diverse DNA differences across various demographics. These datasets enable accurate biomarker visualization, supporting early drug discovery and enhancing the reliability of clinical trial decisions. By addressing the gap in data from minority populations, SökerData improves the understanding of disease outcomes and treatment responses across different groups. The company's services support the identification of biomarkers relating to disease outcomes across demographics, facilitating the development of more effective and inclusive healthcare solutions.
Target Audience
SökerData's primary customers are researchers and organizations involved in early drug discovery and clinical trials who require diverse and unbiased health datasets.
Features
- Curated health datasets representing diverse DNA differences.
- Biomarker visualization tools for early drug discovery.
- Data specifically focused on minority populations to reduce bias.
- Support for clinical trial decisions with reliable and representative data.